BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 10:57:00 AM | Browse: 1106 | Download: 1049
Publication Name World Journal of Stem Cells
Manuscript ID 7173
Country Singapore
Received
2013-11-07 11:25
Peer-Review Started
2013-11-07 17:23
To Make the First Decision
2013-12-25 18:19
Return for Revision
2014-01-23 19:35
Revised
Second Decision
2014-04-03 10:49
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-03 11:02
Articles in Press
2014-05-23 13:17
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-04-13 23:17
Typeset the Manuscript
2014-07-18 11:33
Publish the Manuscript Online
2014-07-19 21:17
ISSN 1948-0210 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac & Cardiovascular Systems
Manuscript Type Minireviews
Article Title Endothelial progenitor cells in cardiovascular diseases
Manuscript Source Invited Manuscript
All Author List Poay Sian Sabrina Lee and Kian Keong Poh
Funding Agency and Grant Number
Funding Agency Grant Number
National Medical Research Council, Singapore NMRC/NIG/1038/2010
National University Health System Clinician Scientist Program
Corresponding Author Kian Keong Poh, MBBChir, FRCP, Professor, Cardiac Department, National University Heart Centre, National University Health System, Singapore and Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, NUHS Tower Block, Level 9, Singapore 119228, Singapore. kian_keong_poh@nuhs.edu.sg
Key Words Endothelial progenitor cells; Cardiovascular diseases; Hypertension; Diabetes; Dyslipidemia; Therapy; Stents
Core Tip Our review summarizes the important associations between endothelial progenitor cells, cardiovascular risks, drugs and diseases. Current pharmacotherapies may enhance endothelial progenitor cell numbers and function. These and the evolving endothelial progenitor cell-based therapies may be important in the future treatment of cardiovascular diseases.
Publish Date 2014-07-19 21:17
Citation Lee PSS, Poh KK. Endothelial progenitor cells in cardiovascular diseases. World J Stem Cells 2014; 6(3): 355-366
URL http://www.wjgnet.com/1948-0210/full/v6/i3/355.htm
DOI http://dx.doi.org/10.4252/wjsc.v6.i3.355
Full Article (PDF) WJSC-6-355.pdf
Full Article (Word) WJSC-6-355.doc
Manuscript File 7173-Review.docx
Answering Reviewers 7173-Answering reviewers.pdf
Copyright License Agreement 7173-Copyright assignment.pdf
Peer-review Report 7173-Peer review(s).pdf
Scientific Editor Work List 7173-Scientific editor work list.doc